Abstract:Abstract Abstract 4716 Aim: Heme oxygenase-1(HO-1) is well characterized survival factor that inhibits apoptosis in tumor cells. Chronic myeloid leukemia (CML) cells constitutively express HO-1 in chronic phase, but express highly in accelerated phase (AP) and blast phase (BP). However, resistance against tyrosine kinase inhibitor (TKI) can occur during therapy with TKI, particularly in AP and BP. This study was designed to confirm the relationship between HO-1 and drug resistant in CML, and seek ways to reversal of TKI resistant. Method: HO-1 gene was cloned from human liver by RT-PCR. And the lentiviral vector pLenti6-GFP-HO-1 was constructed. K562 cells which was expressed HO-1 highly was seemed as gene-transfected group. At the same time, we set the empty vector transfected group and untransfected group. K562 cells was cultivated with dasatinib in gene-transfected, empty vector transfected and untransfected groups. Expression of HO-1 mRNA was demonstrable by RT-PCR and the HO-1 protein by Western blotting. Gene mutation was detected by high performance liquid chromatography (HPLC) analysis. HO-1, multi-drug resistance gene(MDR1), lung reristance-related protein (LRP), glutathione S-transferase-π (GST-π), topoisomerase-I (Topo-I) in mRNA and protein level were deteceted by RT-PCR and Western blot. Apoptosis and cell cycle were determined by flow cytomertry analysis after treated with dasatinib. The activity of HO-1 against dasatinib for CML cells in vivo was evaluated by using the nude mouse xenograft model. The virus was injected into mouse through tail vein. Result: HO-1 gene was cloned successfully from human liver. The sequences were confirmed by restriction enzyme digestion analysis and sequencing. The virus was packaged in 293 cells and titer of virus was tested by Real-Time PCR, 1.02×109v.p./mL. Following transfer the lentiviral vector into K562, 72 hours after transfection, it showed that HO-1 was expressed highest by fluorescence micrope. The expression of HO-1 was detected by RT-PCR and Western blotting. HPLC results showed that there were not gene mutation after transfection□GRT-PCR and Western blot showed that the expression of MDR1 was significantly higher than transfection (P<0.01), also LRP and Topo-I levels were higher than transfection (P<0.05), there was no obvious changes of GST-π after transfection. At 48 hours after treatment with 10umol/L dasatinib by flow cytometry, the survival rate in transfected group was lowest which is 7.2±0.9% (P<0.05). And in empty vector transfected and untransfected group the survival rate was 38.2±1.6% and 39.3±1.7%. Cell cycle results showed that the cell population in G0/G1 and S phases decreased significantly in empty vector transfected and untransfected group, cell cycle arrest at G2/M checkpoint when treated by dasatinib. Nude mouse xenegraft models bearing carcinoma were established successfully. HO-1 in nude mouse xenegraft models was associated with protection of tumor cell against dasatinib. Conclusion: Up-regulating of HO-1 in chronic myeloid leukemia cell is associated with cell growth and anti-apoptotic effect. At the same time, there was a close relationship between HO-1 and resistance gene. HO-1 expression was accompanied by the expression of resistance genes. Based on these data, it seems desirable to explore the value of the HO-1-targeting drug in clinical trials in patients with leukemia and solid tumors. Disclosures: No relevant conflicts of interest to declare.

Inhibition of the NADPH Oxidase Regulates Heme Oxygenase 1 Expression in Chronic Myeloid Leukemia

Induction of Heme Oxygenase-1 by Na+-H+ Exchanger 1 Protein Plays a Crucial Role in Imatinib-resistant Chronic Myeloid Leukemia Cells*

Induction of Na+-H+ Ion Exchanger 1 Protein by Heme Oxygenase-1 Plays a Crucial Role in Imatinib-Resistant Chronic Myeloid Leukemia Cells Via P38/mapk Signaling Pathway

Heme Oxygenase-1(HO-1): A Promising Novel Target Molecule for Overcoming Imatinib Resistance in Chronic Myeloid Leukemia

Protein Kinase C-βii-Dependent Up-Regulation of Heme Oxygenase-1 in Chronic Lymphocytic Leukemia Cells is Crucial for Resistance Against Imatinib

Heme Oxygenase-1 Reduces the Sensitivity to Imatinib Through Nonselective Activation of Histone Deacetylases in Chronic Myeloid Leukemia.

The Effect of Tyrosine Kinase Inhibitor Resistant to CML Cells Which Was Transfected with HO-1 Lentiviral Vector

Heme Oxygenase 1 Overexpression Induces Immune Evasion of Acute Myeloid Leukemia Against Natural Killer Cells by Inhibiting CD48.

Overexpression of Heme Oxygenase-1 in Bone Marrow Stromal Cells Promotes Microenvironment-Mediated Imatinib Resistance in Chronic Myeloid Leukemia

[Effects of HO-1 Gene Expression on Proliferation of Imatinib Resistant CML Cells].

Heme Oxygenase-1 Plays a Crucial Role in Chemoresistance in Acute Myeloid Leukemia.

Heme Oxygenase-1 Inhibition the Cytotoxicity of NK Cells to AML by Downregulating HLA-C

Heme Oxygenase-1 Suppresses the Apoptosis of Acute Myeloid Leukemia Cells Via the JNK/c-JUN Signaling Pathway.

Disruption of Dntp Homeostasis by Ribonucleotide Reductase Hyperactivation Overcomes AML Differentiation Blockade

In vivo and in vitro effects of heme oxygenase-1 silencing on the survival of acute myelocytic leukemia-M2 cells

HNRNPH1 Is a Novel Regulator Of Cellular Proliferation and Disease Progression in Chronic Myeloid Leukemia

Heme oxygenase-1 inhibits the cytotoxicity of natural killer cells to acute myeloid leukemia by downregulating human leukocyte antigen-C

Expression of heme oxygenase and its clinical significance in myelodysplastic syndromes patients

Study on the effect of cell apoptosis about the heme oxygenase-1 to chronic myeloid leukemia

HO-1 Promotes Resistance to an EZH2 Inhibitor Through the Prb-E2f Pathway: Correlation with the Progression of Myelodysplastic Syndrome into Acute Myeloid Leukemia.

[The Effect of Retrovirus-Mediated HO-1 Gene on Chronic Myeloid Leukemia Resistance Cell K562/A02 Apoptosis Induced by Nilotinib].